Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: Evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone

Journal of Clinical Oncology

Volumn 32, Issue 21, 2014, Pages

  Yamada, Osamu ^a   Mahfoudhi, Emna ^b,c   Plo, Isabelle ^b   Ozaki, Kohji ^d   Nakatake, Mayuka ^a   Akiyama, Masaharu ^d   Yamada, Hisashi ^d   Kawauchi, Kiyotaka ^a   Vainchenker, William ^b,d  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b INSERM   (France)

^c PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HEMOGLOBIN; JANUS KINASE 2; NILOTINIB; JAK2 PROTEIN, HUMAN;

AGED; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER CELL; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLONAL EVOLUTION; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE TRANSLOCATION; HEMATOCRIT; HETEROZYGOSITY LOSS; HUMAN; KARYOTYPING; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MYELOID METAPLASIA; NEUTROPHIL; PRIORITY JOURNAL; SOMATIC MUTATION; THROMBOCYTE COUNT; CHRONIC LYMPHATIC LEUKEMIA; GENETICS; MUTATION; PROGNOSIS;

AGED; FUSION PROTEINS, BCR-ABL; HUMANS; JANUS KINASE 2; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MUTATION; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 84905822331     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.8669     Document Type: Article

References (10)

1. James C, Ugo V, Le Couédic JP, et al: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144-1148, 2005 (Pubitemid 40663494)
2. Vardiman JW, Thiele J, Arber DA, et al: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 114:937-951, 2009
3. Baccarani M, Cortes J, Pane F, et al: Chronic myeloid leukemia: An update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27:6041-6051, 2009
4. Norol F, Vitrat N, Cramer E, et al: Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 91:830-843, 1998 (Pubitemid 28078285)
5. Bocchia M, Vannucchi AM, Gozzetti A, et al: Insights into JAK2-V617F mutation in CML. Lancet Oncol 8:864-866, 2007 (Pubitemid 47488062)
6. Bornhäuser M, Mohr B, Oelschlaegel U, et al: Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis. Leukemia 21:1824-1826, 2007 (Pubitemid 47086774)
7. Greaves M, Maley CC: Clonal evolution in cancer. Nature 481:306-313, 2012
8. Plo I, Nakatake M, Malivert L, et al: JAK2 stimulates homologous recombination and genetic instability: Potential implication in the heterogeneity of myeloproliferative disorders. Blood 112:1402-1412, 2008
9. Wang X, Prakash S, Lu M, et al: Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest 22:3888-3899, 2012
10. Cilloni D, Saglio G: Molecular pathways: BCR-ABL. Clin Cancer Res 18:930-937, 2012